Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001345:Autoradiography; D002247:Carbon Isotopes; D003485:Cyanates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003510:Cyclohexanes / Q000008:administration & dosage / Q000494:pharmacology; D003514:Cyclohexylamines / Q000008:administration & dosage / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007939:Leukemia L1210; D051379:Mice; D009603:Nitroso Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014508:Urea / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D003485:Cyanates; D003510:Cyclohexanes; D003514:Cyclohexylamines; D004273:DNA, Neoplasm; D009603:Nitroso Compounds; D009607:Nitrosourea Compounds; D014316:Tritium; D014508:Urea; D013936:Thymidine